Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism LYPLA1 inhibitors(lysophospholipase 1 inhibitors), LYPLA2 inhibitors(lysophospholipase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Eczema | Discovery | - | 20 Mar 2025 | |
Hemic and Lymphatic Diseases | Discovery | - | 20 Mar 2025 | |
Immune System Diseases | Discovery | - | 20 Mar 2025 | |
Nervous System Diseases | Discovery | - | 20 Mar 2025 |